Talent as a Catalyst in Pharmaceuticals
How to maximise business potential with people insights
The pharmaceuticals industry is no stranger to outside criticism, but it is emerging from the pandemic as triumphant. There is a buzz about pharma companies, as the industry doubles down on agility and driving innovation.
While the future looks bright for those that can set the pace of change, pharma business leaders find themselves in the teeth of the toughest recruitment and retention environment for many decades—the so-called Great Resignation. With people matters so high on the agenda, it’s time for the next phase of workforce insights and understanding needed to drive business continuity and success.
This white paper focuses on:
- Connecting people and purpose through DEI and ESG
- Prioritising talent through reorganisations
- The newly distributed, hybrid workforce
- Pushing back against churn and attrition in pharma
Download White Paper
Fill out the form below to gain access to your white paper.
Visier uses the information you provide to us to contact you about our relevant content, products, and services. You can unsubscribe from communications from Visier at any time. For more information, check out Visier's Privacy Statement.